IRCT138710251543N1已完成未知
Evaluation of Clofazimine Effect in Treatment of Cutaneous Leishmaniasis
Fars University of Medical Sciences and Health Services0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12 years 至 139 years（—）
- 性别
- All
入选标准
- •Age more than 12 y/o, duration of disease less than 2month, no anti-leishmania (Glucantim, Rifampin, Azithromycin) treatment since 1 month prior to study,
- •Exclusion criteria: Lesion on face and joint, pregnancy, lactation, severe diseases including hepatic, renal and cardiac diseases
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
2 期
Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)Mycobacterium Avium ComplexNCT02968212Oregon Health and Science University102
尚未招募
不适用
Evaluation of clofazimine as a part of TB treatment in order to shorten the duration of treatmentCTRI/2019/03/018102Indian Council of Medical Research
尚未招募
2 期
A5362: The CLO-FAST StudyCTRI/2021/04/033189IH DAIDS
已完成
2 期
Pharmacokinetic Study With a Loading Dose of Clofazimine in Adult Patients With Nontuberculous Mycobacterial DiseaseNontuberculous Mycobacterial DiseasesNCT05294146Radboud University Medical Center12
终止
2 期
The role of flumazenil infusion in the treatment of benzodiazepine withdrawalBenzodiazepine withdrawalMental Health - AddictionACTRN12616001560482Go Medical Industries Pty Ltd28